Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas

Modern Pathology

Volumn 20, Issue 12, 2007, Pages 1253-1262

  Berkhout, Marloes ^a   Nagtegaal, Iris D ^a   Cornelissen, Sandra J B ^a   Dekkers, Marieke M G ^a   Van De Molengraft, Fred J J M ^b   Peters, Wilbert H M ^a   Nagengast, Fokko M ^a   Van Krieken, J Han J M ^a   Jeuken, Judith W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Comparative genomic hybridization; Duodenal carcinomas; Familial adenomatous polyposis; Hypermethylation; ms mlpa

Indexed keywords

ADENOMATOUS POLYP; ADENOMATOUS POLYPOSIS COLI GENE; ADULT; AGED; ARTICLE; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 20; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DUODENUM CARCINOMA; ESTROGEN RECEPTOR 1 GENE; FEMALE; GENE; H CADHERIN GENE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN SUPERFAMILY GENES MEMBER 4; MALE; METHYLATION; PAIRED BOX GENE 6; PRIORITY JOURNAL; TIMP METALLOPEPTIDASE INHIBITOR 3 GENE;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI; CHROMOSOME ABERRATIONS; DNA METHYLATION; DUODENAL NEOPLASMS; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

EID: 36248932653     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800952     Document Type: Article

References (66)

1. http://www.ikcnet.nl/uploaded/FILES/Landelijk/cijfers/Incidentie%202003/ A1%201989-2003.xls. 2006. Ref Type: Internet Communication.
2. Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998;7:243-251.
3. Dabaja BS, Suki D, Pro B, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-526.
4. Howe JR, Karnell LH, Menck HR, et al. The American college of surgeons commission on cancer and the American cancer society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base 1985-1995. Cancer 1999;86:2693-2706.
5. Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783-785.
6. Persson PG, Karlen P, Bernell O, et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994;107:1675-1679.
7. Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med 2003;115:191-195.
8. Rodriguez-Bigas MA, Vasen HF, Lynch HT, et al. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 1998;83:240-244.
9. Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-616.
10. Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988;1:1149-1151.
11. Bulow S, Bjork J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381-386.
12. Groves CJ, Saunders BP, Spigelman AD, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-641.
13. Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the heidelberg polyposis register. Int J Colorectal Dis 2001;16:63-75.
14. Spigelman AD, Talbot IC, Penna C, et al. Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The leeds castle polyposis group (upper gastrointestinal committee). J Clin Pathol 1994;47:709-710.
15. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-1982.
16. Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-642.
17. Gisselsson D. Chromosome instability in cancer: how, when, and why? Adv Cancer Res 2003;87:1-29.
18. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196:1-7.
19. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003;4:351-358.
20. Blaker H, von Herbay A, Penzel R, et al. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 2002;21:158-164.
21. Chang MC, Chang YT, Tien YW, et al. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization. Oncol Rep 2005;14:867-872.
22. Brucher BL, Geddert H, Langner C, et al. Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel. Int J Cancer 2006;119:1298-1302.
23. Kim SG, Chan AO, Wu TT, et al. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. Gastroenterology 2003;124:1300-1310.
24. Jeuken JW, Sprenger SH, Wesseling P. Comparative genomic hybridization: practical guidelines. Diagn Mol Pathol 2002;11:193-203.
25. van Dijk MC, Rombout PD, Boots-Sprenger SH, et al. Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 2005;14:9-16.
26. Nygren AO, Ameziane N, Duarte HM, et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005;33:128.
27. Hamilton S, Aaltonen LA. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. 1st IARC: Lyon, 2000.
28. Morson B, Sobin LH. Histological Typing of Intestinal Tumours: International Histological Classification of Tumours. WHO: Geneva, 1976.
29. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987;1:1303-1306.
30. Jeuken JWM, Sprenger SHE, Wesseling P, et al. Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 1999;58:606-612.
31. Jeuken JWM, Sprenger SHE, Boerman RH, et al. Subtyping of oligo-astrocytic tumours by comparative genomic hybridisation. J Pathol 2001;194:81-87.
32. Jeuken JWM, Sprenger SHE, Vermeer H, et al. Chromosomal imbalances in primary oligodendroglial tumors and their recurrences; clues for malignant progression as detected by CGH. J Neurosurg 2002;96:559-564.
33. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.
34. Lee S, Hwang KS, Lee HJ, et al. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 2004;84:884-893.
35. Jeuken JWM, Cornelissen SJB, Vriezen M, et al. MSMLPA: an attractive alternative laboratory assay for robust, reliable and quantitative detection of MGMT promoter hypermethylation in gliomas. Lab invest 2007 [August 13; E-pub ahead of print].
36. Bai AH, Tong JH, To KF, et al. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer 2004;112:846-853.
37. Xu XL, Yu J, Zhang HY, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 2004;10:3441-3454.
38. Agnese V, Corsale S, Calo V, et al. Significance of P16INK4A hypermethylation gene in primary head/ neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Ann Oncol 2006;17:vii137-vii141.
39. Lee M, Sup HW, Kyoung KO, et al. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. Pathol Res Pract 2006;202:415-424.
40. van Engeland M, Roemen GM, Brink M, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 2002;21:3792-3795.
41. Wagner KJ, Cooper WN, Grundy RG, et al. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer. Oncogene 2002;21:7277-7282.
42. Salem CE, Markl ID, Bender CM, et al. PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer 2000;87:179-185.
43. Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006;106:483-493.
44. Aragane H, Sakakura C, Nakanishi M, et al. Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization. Int J Cancer 2001;94:623-629.
45. De Angelis PM, Clausen OP, Schjolberg A, et al. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999;80:526-535.
46. Diep CB, Kleivi K, Ribeiro FR, et al. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 2006;45:31-41.
47. Jiang JK, Chen YJ, Lin CH, et al. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases - an analysis by comparative genomic hybridization. Genes Chromosomes Cancer 2005;43:25-36.
48. Kimura Y, Noguchi T, Kawahara K, et al. Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Mod Pathol 2004;17:1328-1337.
49. Peng DF, Sugihara H, Mukaisho K, et al. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol 2003;201:439-450.
50. Schleger C, Arens N, Zentgraf H, et al. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J Pathol 2000;191:27-32.
51. Mahlamaki EH, Hoglund M, Gorunova L, et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 1997;20:383-391.
52. Kwong D, Lam A, Guan X, et al. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004;35:309-316.
53. Rosenberg C, Van Gurp RJ, Geelen E, et al. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene 2000;19:5858-5862.
54. Hughes S, Williams RD, Webb E, et al. Meta-analysis and pooled re-analysis of copy number changes in colorectal cancer detected by comparative genomic hybridization. Anticancer Res 2006;26:3439-3444.
55. Stuart ET, Kioussi C, Gruss P. Mammalian Pax genes. Annu Rev Genet 1994;28:219-236.
56. Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology 2004;145:2639-2644.
57. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130-1134.
58. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989;8:1711-1717.
59. Funayama N, Fagotto F, McCrea P, et al. Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J Cell Biol 1995;128:959-968.
60. Behrens J. Control of beta-catenin signaling in tumor development. Ann NY Acad Sci 2000;910:21-33.
61. Hadjihannas MV, Bruckner M, Jerchow B, et al. Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer. Proc Natl Acad Sci USA 2006;103:10747-10752.
62. Bui TD, Rankin J, Smith K, et al. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene 1997;14:1249-1253.
63. Griffin CA, Lazar S, Hamilton SR, et al. Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas. Cancer Genet Cytogenet 1993;67:14-20.
64. Muleris M, Nordlinger B, Dutrillaux B. Cytogenetic characterization of a colon adenocarcinoma from a familial polyposis coli patient. Cancer Genet Cytogenet 1989;38:249-253.
65. Yoshida MA, Ikeuchi T, Iwama T, et al. Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis. Jpn J Cancer Res 1991;82:916-921.
66. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by highresolution microarray comparative genomic hybridization. J Pathol 2003;200:320-326.